|
| Status |
Public on Oct 03, 2014 |
| Title |
BPDCN_21 |
| Sample type |
RNA |
| |
|
| Source name |
BPDCN Patient
|
| Organism |
Homo sapiens |
| Characteristics |
tumor type: BPDCN
phenotype: BPDCN Patient
|
| Treatment protocol |
Treatment with imatinib mesylate (0 and 1 microM) for 6 hours
|
| Extracted molecule |
total RNA |
| Extraction protocol |
total RNA from cryopreserved and FFPE samples was extracted using TRIzol reagent (Invitrogen) and the RecoverAll Total Nucleic Acid Isolation Kit (Ambion, Austin, TX), respectively, following the manufacturer's protocols
|
| Label |
biotin
|
| Label protocol |
Standard 29K Whole-Genome DASL HT Assay label protocol (WGDASL HT Assay Guide (15018210 D)
|
| |
|
| Hybridization protocol |
Standard 29K Whole-Genome DASL HT Assay hybridization protocol (WGDASL HT Assay Guide (15018210 D)
|
| Scan protocol |
Standard 29K Whole-Genome DASL HT Assay scan protocol (WGDASL HT Assay Guide (15018210 D)
|
| Data processing |
Gene expression analysis was carried according to MIAME guidelines.
|
| |
|
| Submission date |
Oct 02, 2014 |
| Last update date |
Oct 03, 2014 |
| Contact name |
Fabio Fuligni |
| E-mail(s) |
fabio.fuligni2@unibo.it
|
| Organization name |
University of Bologna
|
| Department |
Department of Experimental, Diagnostic, and Specialty Medicine Bologna University Medical School
|
| Lab |
Unit of Hematopathology
|
| Street address |
Via Massarenti 9
|
| City |
Bologna |
| ZIP/Postal code |
40138 |
| Country |
Italy |
| |
|
| Platform ID |
GPL18281 |
| Series (1) |
| GSE62014 |
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to nf-kb pathway inhibition |
|
